课题基金 / 基金详情

Development of a novel treatment for inflammatory bowel disease via the regulation of the bacteria recognition system and effective molecules derived from bacteria

Development of a novel treatment for inflammatory bowel disease via the regulation of the bacteria recognition system and effective molecules derived from bacteria
通过调节细菌识别系统和细菌衍生的有效分子开发炎症性肠病的新型治疗方法
批准号:
19390194
负责人:
KOHGO Yutaka
金额:
$10.07万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

KOHGO Yutaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The present study proposed a novel system of host-microbial interactions based on the sensing of bacterial secretions by epithelial membrane molecules such as transporters, leading to the maintenance of intestinal homeostasis. This novel system mainly mediates the interaction between the host and probitoics, including bacilli and lactobacilli. Conversely, this study also showed that human defensin (HD) 5 and 6, which are representative anti-microbial peptides secreted from the intestinal epithelia, possess an anti-inflammatory effect. Furthermore, HD-5 secretion was induced by isoleucine, which is an amino acid. The present study indicated that these effective molecules, including bacterial secretions, and HDs, and an amino acid (isoleucine), appear to be a novel potential compound for the treatment of intestinal disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heat-killed Lactobaccilus brevis SBC8803 improves intestinal injury in a murine model of colitis by protecting the intestinal epithelia and regulating pro-inflammatory cytokines.
热灭活短乳杆菌 SBC8803 通过保护肠上皮和调节促炎细胞因子来改善小鼠结肠炎模型中的肠道损伤。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Ueno N, Fujiya M, Kohgo Y.]
通讯作者: Kohgo Y.
Heat killed Lactobaccilus brevis SBC8803 improves intestinal injury in a murine model of colitis via the enhancement of the intestinal barrier function and the down-regulation of pro-inflammatory cytokines.
热灭活短乳杆菌 SBC8803 通过增强肠道屏障功能和下调促炎细胞因子来改善小鼠结肠炎模型中的肠道损伤。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Fujiya M, Ueno N, Segawa S, Nata T, Moriichi K, Tanabe H, Mizukami Y, Kobayashi N, Ito K, Kohgo Y]
通讯作者: Kohgo Y
Infliximab may prevent post-operative recurrences in Crohn's disease.
英夫利昔单抗可以预防克罗恩病术后复发。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [K.Okamoto, T.Ashida, R.Sugiyama, T.Nata, Y.Nomura, N.Ueno, C.Ishikawa, Y.Inaba, T.Ito, K.Moriihi, H.Tanabe, M.Fujiya, Y.Kohgo]
通讯作者: Y.Kohgo
DOI: 10.1016/j.chom.2007.05.004
发表时间: 2007-06-01
期刊: CELL HOST & MICROBE
影响因子: 30.3
作者: [Fujiya, Mikihiro, Musch, Mark W., Chang, Eugene B.]
通讯作者: Chang, Eugene B.
41
    Cytoprotective effects of bioactive molecules derived from bacteria in the intestinal biofilm
    • 批准号:
      22390148
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2010
    • 负责人:
      KOHGO Yutaka
    • 依托单位:
    The role of innate immunity in inflammatory bowel disease
    • 批准号:
      15390223
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2003
    • 负责人:
      KOHGO Yutaka
    • 依托单位:
    ISOLATION AND STRUCTURE ANALYSIS OF SOLUBLE TRANSFERIN RECEPTOR FOR INTERNATIONAL ASSAY SYSTEM
    • 批准号:
      11557071
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.97万
    • 财政年份:
      1999
    • 负责人:
      KOHGO Yutaka
    • 依托单位:
    INTRINSIC ANTIMICROBIAL POLYPEPTIDE IN INFLAMMATROY BOWEL DISEASE
    • 批准号:
      11694231
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.18万
    • 财政年份:
      1999
    • 负责人:
      KOHGO Yutaka
    • 依托单位:
    海外基金